These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28461564)

  • 1. Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.
    Larimer BM; Wehrenberg-Klee E; Dubois F; Mehta A; Kalomeris T; Flaherty K; Boland G; Mahmood U
    Cancer Res; 2017 May; 77(9):2318-2327. PubMed ID: 28461564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging.
    Larimer BM; Bloch E; Nesti S; Austin EE; Wehrenberg-Klee E; Boland G; Mahmood U
    Clin Cancer Res; 2019 Feb; 25(4):1196-1205. PubMed ID: 30327313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Granzyme B-targeted Smart Positron Emission Tomography Probes for Monitoring Tumor Early Response to Immunotherapy.
    Fu J; Xi H; Cai S; Peng Y; Liu Q; Qiu L; Lin J
    ACS Nano; 2024 Jul; 18(29):18910-18921. PubMed ID: 39001856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granzyme B PET imaging of immune-mediated tumor killing as a tool for understanding immunotherapy response.
    LaSalle T; Austin EE; Rigney G; Wehrenberg-Klee E; Nesti S; Larimer B; Mahmood U
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy.
    Chen M; Zhou K; Dai SY; Tadepalli S; Balakrishnan PB; Xie J; Rami FEI; Dai T; Cui L; Idoyaga J; Rao J
    Cell Chem Biol; 2022 Oct; 29(10):1556-1567.e6. PubMed ID: 36103874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining Immunotherapy Response Using Multiple Radiotracers.
    Goggi JL; Hartimath SV; Hwang Y; Tan YX; Khanapur S; Ramasamy B; Jiang L; Yong FF; Cheng P; Tan PW; Husaini MA; Yuen TY; Jieu B; Chacko AM; Larbi A; Renia L; Johannes C; Robins EG
    Mol Imaging Biol; 2020 Aug; 22(4):993-1002. PubMed ID: 32006204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granzyme B PET Imaging of the Innate Immune Response.
    Capaccione KM; Doubrovin M; Bhatt N; Mintz A; Molotkov A
    Molecules; 2020 Jul; 25(13):. PubMed ID: 32646038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive interrogation of CD8+ T cell effector function for monitoring early tumor responses to immunotherapy.
    Zhou H; Wang Y; Xu H; Shen X; Zhang T; Zhou X; Zeng Y; Li K; Zhang L; Zhu H; Yang X; Li N; Yang Z; Liu Z
    J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35788116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging the Granzyme Mediated Host Immune Response to Viral and Bacterial Pathogens
    Pandey A; Chopra S; Cleary SJ; López-Álvarez M; Quimby FM; Alanizi AAA; Sakhamuri S; Zhang N; Looney MR; Craik CS; Wilson DM; Evans MJ
    ACS Infect Dis; 2024 Jun; 10(6):2108-2117. PubMed ID: 38819300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer.
    Goggi JL; Hartimath SV; Xuan TY; Khanapur S; Jieu B; Chin HX; Ramasamy B; Cheng P; Rong TJ; Fong YF; Yuen TY; Msallam R; Chacko AM; Renia L; Johannes C; Hwang YY; Robins EG
    Mol Imaging Biol; 2021 Oct; 23(5):714-723. PubMed ID: 33713000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination.
    Collignon A; Perles-Barbacaru AT; Robert S; Silvy F; Martinez E; Crenon I; Germain S; Garcia S; Viola A; Lombardo D; Mas E; Béraud E
    Oncotarget; 2015 Sep; 6(27):23462-79. PubMed ID: 26405163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of granzyme B antigen in cytotoxic cells in human tissues.
    Hameed A; Truong LD; Price V; Kruhenbuhl O; Tschopp J
    Am J Pathol; 1991 May; 138(5):1069-75. PubMed ID: 2024702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy.
    Nguyen A; Ramesh A; Kumar S; Nandi D; Brouillard A; Wells A; Pobezinsky L; Osborne B; Kulkarni AA
    Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma.
    van Houdt IS; Oudejans JJ; van den Eertwegh AJ; Baars A; Vos W; Bladergroen BA; Rimoldi D; Muris JJ; Hooijberg E; Gundy CM; Meijer CJ; Kummer JA
    Clin Cancer Res; 2005 Sep; 11(17):6400-7. PubMed ID: 16144945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of tumor-infiltrating lymphocyte efficacy in melanoma.
    Zikich D; Schachter J; Besser MJ
    Immunotherapy; 2016; 8(1):35-43. PubMed ID: 26653685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating antigen-specific cytotoxicity of CD8+ T cells in fish by granzyme B-like activity.
    Toda H; Yabu T; Shiba H; Moritomo T; Nakanishi T
    Vet Immunol Immunopathol; 2011 May; 141(1-2):168-72. PubMed ID: 21435730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies.
    Scott JI; Mendive-Tapia L; Gordon D; Barth ND; Thompson EJ; Cheng Z; Taggart D; Kitamura T; Bravo-Blas A; Roberts EW; Juarez-Jimenez J; Michel J; Piet B; de Vries IJ; Verdoes M; Dawson J; Carragher NO; Connor RAO; Akram AR; Frame M; Serrels A; Vendrell M
    Nat Commun; 2022 May; 13(1):2366. PubMed ID: 35501326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decreased susceptibility of metastatic melanoma cells to killing involves an alteration of CTL reactivity.
    Gassara A; Messai Y; Gaudin C; Abouzahr S; Jalil A; Diarra-Mehrpour M; Faure F; Richon C; Avril MF; Even J; Chouaib S
    Int J Oncol; 2006 Jul; 29(1):155-61. PubMed ID: 16773195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.